Tiotropium HandiHaler(®) in the treatment of COPD: A safety review

BACKGROUND: Tiotropium is a long-acting inhaled anticholinergic developed for the treatment of chronic obstructive pulmonary disease (COPD) and has been available since 2002. We sought to update an evaluation of the safety of tiotropium in the HandiHaler(®) formulation as significant clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesten, Steven, Celli, Bart, Decramer, Marc, Leimer, Inge, Tashkin, Donald
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793068/
https://www.ncbi.nlm.nih.gov/pubmed/20037679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793068/
https://www.ncbi.nlm.nih.gov/pubmed/20037679

Ejemplares similares